ClinicalTrials.gg
Status unknownNCT03345862ASySUpdated Jul 14, 2020

Effectiveness of a Intervention to Reduce the Social Isolation and Loneliness of Elderly Residents at Home

An interventional study of non-pharmacological multicomponent in Social Isolation, Loneliness (Descriptors Included in the MeSH), sponsored by Andaluz Health Service. Status unknown at 1 site in Spain. Open to participants aged 65 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-07-14.

Sponsored by Andaluz Health Service · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Jul 2020), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
114
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 15 studies in Social Isolation with a site in Spain — 4 open to participants now, 6 under way, none of them phase 3. Social Isolation · Spain.

Planned enrollment
4th of 12
114 · median 82
Started
2018
with 1 other
No phase
10 of 15
3 open now
Registered
1st of 15
by date
Lead sponsor
1 of 15
Andaluz Health Service

Among the 15 studies in Social Isolation with a site in Spain, this one is the 4th largest by planned enrollment of the 12 interventional ones that give a count, is one of 2 that started in 2018, is one of 10 with no phase, and was the 1st registered.

Social Isolation

236 studies on the registry are indexed under Social Isolation; 61 are open to participants now.

This study's planned enrollment of 114 is above the median of 80 across 198 interventional studies indexed under Social Isolation.

Browse Social Isolation studies →

Open to participants now

4 of the 15 studies in Social Isolation with a site in Spain are open now.

All 4 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 34 Social Isolation studies recruiting now, 22 (65%) set no upper age limit and 6 (18%) stop at 75 or younger; 4 take children under 18; 18 take healthy volunteers.

This study: 65 Years and older · all sexes · healthy volunteers too.

The full table on the hub →
Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 15 studies in Social Isolation with a site in Spain, or all of them as a file.
02

Study summary

  • Objectives: To evaluate the effectiveness, in terms of reducing social isolation and improving the Health Related Quality of Life (HRQOL), of a non-pharmacological multicomponent intervention in elderly telecare users.
  • Design: Clinical trial randomized by cluster, multicentric.
  • Location: 14 health centers of the Andalusian Health Service (Spain).
  • Subjects and methods: Subjects with social isolation. Age 65 or older. Residents in your home. Persons with cognitive impairment or dementia, difficulty in responding to scales, legal incapacitation or not giving consent will be excluded.

    9 health centers will be randomly assigned to the intervention and control groups. The people of both groups will be evaluated at baseline, at 4 and at 6 months. 57 subjects will be included in each group (n = 114).

Variables: a) Independent: of the professional and of the patients (sociodemographic, healthcare, morbidity, intervention performed -multicomponent vs. non-intervention-) b) Dependents: social support, loneliness and HRQoL.

The intervention includes 8 sessions at home [1 hour], every 15 days and 4 telephone [30 minutes] -1 monthly-. To measure the effectiveness of the intervention, the Duke-UNC Functional Social Support Questionnaire (DUFSS), the De Jong-Gierveld Scale of loneliness, and the EuroQol-5D will be used to measure HRQoL.

Univariate, bivariate and multivariate statistical analysis (multiple linear regression).

-Aspects ethico-legal: Standards of good clinical practice and ethical principles of the Declaration of Helsinki. Informed consent. Application for authorization to the management of the Sanitary District.

Read the detailed description

-Subjects and methods: Subjects with social isolation. Age 65 or older. Residents in your home. Telecare users. Persons with cognitive impairment or dementia, difficulty in responding to scales, legal incapacitation or not giving consent will be excluded.

9 health centers will be randomly assigned to the intervention and control groups. The people of both groups will be evaluated at baseline, at 4 and at 6 months. 57 subjects will be included in each group (n = 114).

Variables: a) Independent: of the professional and of the patients (sociodemographic, healthcare, morbidity, intervention performed -multicomponent vs. non-intervention-) b) Dependents: social support, loneliness and HRQoL.

The intervention includes 6 sessions at home [30-60 minutes], every 15 days and 5 telephone [20 minutes] -1 monthly-. To measure the effectiveness of the intervention, the Duke-UNC Functional Social Support Questionnaire (DUFSS), the De Jong-Gierveld Scale of loneliness, and the EuroQol-5D will be used to measure HRQoL. Analysis by intention to treat. Univariate, bivariate and multivariate statistical analysis (multiple linear regression).

-Aspects ethico-legal: Standards of good clinical practice and ethical principles of the Declaration of Helsinki. Informed consent. Application for authorization to the management of the Sanitary District. Approval of the Ethics and Clinical Research Committee.

03

Conditions studied

  • Social Isolation, Loneliness (Descriptors Included in the MeSH)

Browse trials for

Keywords

  • Social isolation, Loneliness, Health Related Quality of Life
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Age 65 years or older.
  2. Residents in your home (not institutionalized).
  3. Present social isolation: score less than 32 (social support perceived low) with the Duke-UNC Functional Social Support Questionnaire (DUFSS).

Exclusion criteria

Exclusion Criteria:

  1. Cognitive impairment (Mini-mental \<22), or medical diagnosis of dementia.
  2. Difficulty responding to measurement scales due to language barriers.
  3. Legal incapacitation.
  4. Do not grant consent for participation in the study.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
114 participants (estimated)

Study arms

  • Experimental
    Intervention

    Non-pharmacological multicomponent intervention

    Behavioral: non-pharmacological multicomponent

  • No intervention
    Control

    Not intervention, usual attention

Interventions

  • Behavioralnon-pharmacological multicomponent

    Following the proposal of Nicholson \& Shellman, (2013) collected in its CARELINK program, an intervention is proposed that includes: 6 sessions at home \[30-60 minutes\] for 16 weeks (1 fortnightly session) and 5 telephone sessions \[20 min.\] That will be intercalated (in the 16 weeks) depending on the particular characteristics of each person. The first visit, aimed at defining objectives and creating a relationship of trust for future visits.

06

What researchers measure

Primary outcomes

  1. Social isolation

    Duke-UNC Functional Social Support Questionnaire (DUFSS), which reflects the opinion on the availability of other people to offer help in difficulties, skills in social relations and empathic and emotional communication.

    Time frame: 6 months

  2. loneliness

    De Jong-Gierveld de Soledad Scale, which assesses individual subjective perception of social participation or isolation in the elderly population.

    Time frame: 6 months

Secondary outcomes

  1. Health Related Quality of Life

    Health Related Quality of Life (EuroQol-5D scale)

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
  • Luis Angel Perula de Torres
    Córdoba, Andalucía 14011, Spain
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2018 to primary completion in Apr 2020, 22 months.

Of 155 non-industry interventional studies with no phase under Social Isolation, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 36. This study's 22 months is above that.

Counting every sponsor, half of 156 studies reached it within 18 months; a quarter within 10 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 14, 2017
First posted
Nov 17, 2017
StartActual
May 15, 2018
Primary completionActual
Apr 1, 2020
CompletionEst.
Aug 1, 2020
Last update
Jul 14, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 14, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03345862
Lead sponsor
Andaluz Health Service
Responsible party
Luis Angel Perula de Torres (Dr. Ph., Andaluz Health Service) — Principal investigator
First posted
Nov 17, 2017
Start date
May 15, 2018
Primary completion
Apr 1, 2020
Completion
Aug 1, 2020 (estimated)
Last update
Jul 14, 2020

Study contacts

Luis Angel P de Torres
Contact
luisangel.perula@gmail.com
+34 4659681627
Carlos Perula de Torres
Contact
carlxz26@gmail.com
+34659681627

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion